Phase 2 Irritable Bowel Syndrome Trial, Recruiting NCT05776914 Sponsor: Madhusudan (Madhu) Grover, MBBS Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Phase 2 Irritable Bowel Syndrome Trial, Recruiting

NCT05776914
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Irritable Bowel Syndrome (IBS) according to a specific standard set of medical guidelines called the Rome IV criteria.
  • Your IBS is not the type that mainly causes constipation (known as IBS-C).
  • Your IBS symptoms are moderate to severe, based on a specific symptom scoring tool (confirm with trial site if unsure of your score).
  • You are able and willing to safely have a colonoscopy (a procedure to look inside your bowel).

Who may not be able to join:

  • You have a weakened immune system, or you take medications that suppress your immune system.
  • You have a serious bowel or other medical condition that means you cannot safely take the bowel-clearing preparation needed before a colonoscopy.
  • You have a serious bowel or other medical condition that means you cannot safely have a colonoscopy under mild sedation.
  • You currently have active cancer.
  • You are pregnant or breastfeeding.
  • You have had certain types of abdominal surgery (some surgeries are exceptions — confirm with the trial site which surgeries may or may not affect your eligibility).
  • You have a severe mental health condition, or a diagnosed problem with alcohol or drug misuse.
  • You have recently started taking probiotics, or have used antibiotics or anti-inflammatory painkillers (such as ibuprofen) within the last 4 weeks.
  • You currently use medications known to affect how your bowel moves (with the exception of loperamide).
  • You have a diagnosed bleeding disorder.
  • You have been diagnosed with an inflammatory bowel disease (such as Crohn's disease or Ulcerative Colitis), coeliac disease, or microscopic colitis.
  • You have chronic kidney or liver disease.
  • Your blood test shows a very low level of a specific type of white blood cell called neutrophils (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Madhusudan Grover, MBBS, Mayo Clinic

Phone: 507-538-7774

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Madhusudan (Madhu) Grover, MBBS
Registry
ClinicalTrials.gov
Start date
15 April 2024
Est. completion
26 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of responders

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov